The ORA has prepared a comprehensive document that explains the E078 billing issue and why it may jeopardize the future of patient care in Ontario if not resolved quickly. ORA Position: E078 Needs […]
Please see the OMA Bulletin Here: OHIP Bulletin: Submitting K083 Code […]
Please find information on this program here: OHIP Bulletin – Advance Payment Program […]
Delayed Funding for Virtual Care Puts New Rheumatologists at Risk of Closure, Affecting Patient Care During COVID-19 Every Ontarian has been affected by COVID-19, including recently graduated rheumatologists. New rheumatologists have stepped-up to […]
The ORA has published an official position statement on this topic: Position on OHIP Funding We also draw your attention to the OMA’s Protect Healthcare initiative #DotheRightThing […]
We Are Providing Excellent Virtual Care to Our Patients During COVID-19. We Need Your Support to Continue Looking After You!
A Message from the ORA President, Dr. Jane Purvis Re: Doctors against Covid #DoTheRightThing When social distancing measures were implemented last month, the rheumatology community quickly adapted in order to provide virtual care […]
Please do not submit any of the new virtual care billing codes including K083 until directed by the OMA and the Ministry that this code can be accepted by OHIP computers. There has […]
At the April 7, ORA Virtual Town Hall, Janet Gallant from OTN was able to answer many of your questions, including how to sign up! We are pleased to share the following instructions […]
New Rituximab Biosimilar Now Available! + Actemra Auto Injector & Pre-filled Syringe Approved by EAP!
Effective today, March 31, Truxima (rituximab) has new LU codes for RA. Here is the information shared by the Ministry: Truxima (rituximab) 100mg/10mL, 500mg/50mL – Inj Sol (CEH) LU Code 575 For the […]